mwb research downgraded Stratec to Sell. Stratec stock gains 1.49 percent

Published on 10/15/2026 at 12:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

mwb research kept its EUR 21.00 target after a Sell downgrade on September 17, 2026. Stratec stock costs EUR 23.80 on October 15, 2026, 1.49 percent above the Xetra close.

mwb research downgrades Stratec

mwb research downgraded Stratec from Hold to Sell and kept its EUR 21.00 target on September 17, 2026.
Second-quarter revenue reached EUR 59.10 million, while net income rose to EUR 4.20 million in fiscal 2026.
Stratec stock trades at EUR 23.80 at 12:38 p.m. CEST at Lang & Schwarz on October 15, 2026, 1.49 percent above the Xetra close of October 14, 2026.

Bauhaus-Poster mit geometrischen Formen, Mikroskop-Symbol und Schriftzug MEDTECH — Stratec SE (DE000STRA555) prägt die Medizintechnik-Branche, dargestellt als geometrisches Bauhaus-Poster mit Laborsymbolik, Illustration mit AI erstellt.

Stratec stock (ISIN DE000STRA555) trades at EUR 23.80 at Lang & Schwarz on October 15, 2026, 1.49 percent above the Xetra close of October 14, 2026 at EUR 23.45. The latest analyst signal remains cautious: mwb research downgraded Stratec from Hold to Sell and kept its EUR 21.00 price target on September 17, 2026, according to FinanzNachrichten.

Three dates show the recovery

On August 14, 2026, Stratec reported second-quarter revenue of EUR 59.10 million and net income of EUR 4.20 million for the period ended June 30, 2026. On September 17, 2026, mwb research cut its rating from Hold to Sell while retaining the EUR 21.00 target. On October 14, 2026, the Xetra share price reached EUR 24.45 during the session and closed with the previous-day reference at EUR 23.45.

What does the downgrade mean for margins?

The criticism centers on execution rather than the second-quarter rebound. boersengefluester.de reported that EBIT improved from EUR 2.25 million to EUR 5.57 million in the second quarter, lifting the EBIT margin to 9.40 percent. The company also outlined currency-adjusted revenue growth in the mid- to high-single-digit range for 2026 and an adjusted EBIT margin of about 10 percent, while its medium-term ambition reaches at least 13 percent by 2028.

Next reporting date is November 5

Stratec is scheduled to publish third-quarter figures on November 5, 2026, according to boersengefluester.de. That release will test whether the second-quarter improvement carried into the second half and whether the margin path can support the 2026 outlook.

Stock price stays above the target

The Lang & Schwarz quote places Stratec EUR 2.80 above mwb research's EUR 21.00 target, while the stock remains EUR 5.65 below the current 52-week high of EUR 29.45. For investors, the next results therefore matter because the rating downgrade points to delivery risk even as the second-quarter figures showed stronger profitability.

Stratec was trading at EUR 23.80 at Lang & Schwarz on October 15, 2026 at 12:38 p.m. CEST, 1.49 percent above the Xetra close of October 14, 2026 at EUR 23.45. The further course of trading is shown by the continuously updated real-time quote of Stratec stock.